Home
ARGX
ARGX News

Latest argenx SE (ARGX) News on July 10, 2025

High Growth Tech Stocks In Europe To Watch June 2025

Simply Wall St.

14 days ago

High Growth Tech Stocks In Europe To Watch June 2025

Exploring High Growth Tech Stocks In Europe June 2025

Simply Wall St.

15 days ago

Exploring High Growth Tech Stocks In Europe June 2025

High Growth Tech Stocks In Europe Featuring Ubisoft Entertainment And Two Others

Simply Wall St.

15 days ago

High Growth Tech Stocks In Europe Featuring Ubisoft Entertainment And Two Others

Argenx Secures EC Approval for Subcutaneous VYVGART in CIDP Treatment

Insider Monkey

16 days ago

Argenx Secures EC Approval for Subcutaneous VYVGART in CIDP Treatment

High Growth Tech Stocks To Watch In June 2025

Simply Wall St.

17 days ago

High Growth Tech Stocks To Watch In June 2025

argenx Announces European Commission Approval of VYVGART Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy

GlobeNewswire

20 days ago

argenx Announces European Commission Approval of VYVGART Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy

High Growth Tech Stocks in Europe for June 2025

Simply Wall St.

22 days ago

High Growth Tech Stocks in Europe for June 2025

High Growth Tech Stocks In Europe To Watch

Simply Wall St.

23 days ago

High Growth Tech Stocks In Europe To Watch

argenx Presents New Efgartigimod Data at EULAR 2025 Highlighting Positive Phase 2 Proof-of-Concept Results in Myositis and Sjogren’s Disease

GlobeNewswire

a month ago

argenx Presents New Efgartigimod Data at EULAR 2025 Highlighting Positive Phase 2 Proof-of-Concept Results in Myositis and Sjogren’s Disease

High Growth Tech Stocks To Watch In Europe June 2025

Simply Wall St.

a month ago

High Growth Tech Stocks To Watch In Europe June 2025

argenx SE (ARGX): A Bull Case Theory

Insider Monkey

a month ago

argenx SE (ARGX): A Bull Case Theory

This IBD 50 Biotech's Got 'Rhythm' — And Flashes 3 Telltale Clues

Investor's Business Daily

a month ago

This IBD 50 Biotech's Got 'Rhythm' — And Flashes 3 Telltale Clues

Nurix Therapeutics (NRIX) Moves 14.2% Higher: Will This Strength Last?

Zacks

a month ago

Nurix Therapeutics (NRIX) Moves 14.2% Higher: Will This Strength Last?

argenx to Present at Goldman Sachs 46th Annual Global Healthcare Conference

GlobeNewswire

a month ago

argenx to Present at Goldman Sachs 46th Annual Global Healthcare Conference

Argenx added to Best Ideas List at Wedbush

TipRanks

a month ago

Argenx added to Best Ideas List at Wedbush

argenx Announces Results of Annual General Meeting of Shareholders

GlobeNewswire

a month ago

argenx Announces Results of Annual General Meeting of Shareholders

MT Newswires

a month ago

Argenx Set to See Further Growth Due to Vyvgart Momentum, Pipeline Expansion, Wedbush Says

argenx SE (ARGX): Among the Best Growth Stocks to Buy and Hold for the Long Term

Insider Monkey

2 months ago

argenx SE (ARGX): Among the Best Growth Stocks to Buy and Hold for the Long Term

Argenx (ARGX) Upgraded to Buy: Here's Why

Zacks

2 months ago

Argenx (ARGX) Upgraded to Buy: Here's Why

Morningstar Research

2 months ago

Analyst Report: argenx SE

argenx SE (ARGX): Among the Best Cancer Stocks to Invest in for Long-Term Gain

Insider Monkey

2 months ago

argenx SE (ARGX): Among the Best Cancer Stocks to Invest in for Long-Term Gain

argenx SE (ARGX) Q1 2025 Earnings Call Highlights: Record Growth and Strategic Advances

GuruFocus.com

2 months ago

argenx SE (ARGX) Q1 2025 Earnings Call Highlights: Record Growth and Strategic Advances

MT Newswires

2 months ago

Sector Update: Health Care Stocks Decline Pre-Bell Thursday

Argenx Beats Sales Expectations — But Not By Enough — And Shares Tumble

Investor's Business Daily

2 months ago

Argenx Beats Sales Expectations — But Not By Enough — And Shares Tumble

MT Newswires

2 months ago

Argenx Reports Q1 Earnings, Higher Operating Income; Shares Down Pre-Bell

argenx Reports First Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire

2 months ago

argenx Reports First Quarter 2025 Financial Results and Provides Business Update

argenx SE (ARGX): A Bull Case Theory

Insider Monkey

2 months ago

argenx SE (ARGX): A Bull Case Theory

argenx to Present at BofA Securities 2025 Health Care Conference

GlobeNewswire

2 months ago

argenx to Present at BofA Securities 2025 Health Care Conference

Is argenx SE (ARGX) the Most Profitable Growth Stock to Buy Now?

Insider Monkey

2 months ago

Is argenx SE (ARGX) the Most Profitable Growth Stock to Buy Now?

Exploring High Growth Tech Stocks In Europe

Simply Wall St.

2 months ago

Exploring High Growth Tech Stocks In Europe

argenx to Report First Quarter 2025 Financial Results and Business Update on May 8, 2025

GlobeNewswire

2 months ago

argenx to Report First Quarter 2025 Financial Results and Business Update on May 8, 2025

Argenx Stock Extends Rally In A Base As Earnings Loom

Investor's Business Daily

2 months ago

Argenx Stock Extends Rally In A Base As Earnings Loom

MT Newswires

2 months ago

Argenx Gets Positive Committee Opinion in Europe for Autoimmune Disorder Treatment

argenx Announces Positive CHMP Opinion for VYVGART (efgartigimod alfa) Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

GlobeNewswire

2 months ago

argenx Announces Positive CHMP Opinion for VYVGART (efgartigimod alfa) Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Argenx (ARGX) Moves 4.4% Higher: Will This Strength Last?

Zacks

3 months ago

Argenx (ARGX) Moves 4.4% Higher: Will This Strength Last?

Is Argenx SE (ARGX) the Best Growth Stock to Buy According to Billionaires?

Insider Monkey

3 months ago

Is Argenx SE (ARGX) the Best Growth Stock to Buy According to Billionaires?

FDA Approves Argenx's Vyvgart Hytrulo Prefilled Syringe For Self-Injection For At Home Use Setting

Benzinga

3 months ago

FDA Approves Argenx's Vyvgart Hytrulo Prefilled Syringe For Self-Injection For At Home Use Setting

argenx Announces Annual General Meeting of Shareholders on May 27, 2025

GlobeNewswire

3 months ago

argenx Announces Annual General Meeting of Shareholders on May 27, 2025

Argenx Bounds Off 200-Day Line On 'Best-Case Scenario' For Blockbuster Drug

Investor's Business Daily

3 months ago

Argenx Bounds Off 200-Day Line On 'Best-Case Scenario' For Blockbuster Drug

MT Newswires

3 months ago

Halozyme Therapeutics Reports FDA Approval for Self-Injectable Syringe Developed in Partnership With Argenx

argenx Announces FDA Approval of VYVGART Hytrulo Prefilled Syringe for Self-Injection in Generalized Myasthenia Gravis and Chronic Inflammatory Demyelinating Polyneuropathy

GlobeNewswire

3 months ago

argenx Announces FDA Approval of VYVGART Hytrulo Prefilled Syringe for Self-Injection in Generalized Myasthenia Gravis and Chronic Inflammatory Demyelinating Polyneuropathy

argenx SE (ARGX): Among the Aggressive Stocks Picked by Hedge Funds

Insider Monkey

3 months ago

argenx SE (ARGX): Among the Aggressive Stocks Picked by Hedge Funds

Argenx's Flagship Drug Vyvgart Shows Sustained Disease Control In Rare Neuromuscular Disease Patients

Benzinga

3 months ago

Argenx's Flagship Drug Vyvgart Shows Sustained Disease Control In Rare Neuromuscular Disease Patients

argenx Highlights VYVGART Data at AAN 2025 Setting New Standard in Sustained Efficacy and Improved Quality of Life Measures for Patients Living with gMG and CIDP

GlobeNewswire

3 months ago

argenx Highlights VYVGART Data at AAN 2025 Setting New Standard in Sustained Efficacy and Improved Quality of Life Measures for Patients Living with gMG and CIDP

Is Argenx SE (ARGX) The Most Profitable Biotech Stock To Buy Right Now?

Insider Monkey

3 months ago

Is Argenx SE (ARGX) The Most Profitable Biotech Stock To Buy Right Now?

Exploring Three High Growth Tech Stocks in Europe

Simply Wall St.

3 months ago

Exploring Three High Growth Tech Stocks in Europe

Argenx (ARGX) Surges 4.1%: Is This an Indication of Further Gains?

Zacks

4 months ago

Argenx (ARGX) Surges 4.1%: Is This an Indication of Further Gains?

Artisan Small Cap Fund Sold argenx SE (ARGX) as it Exceeded Small-Cap Mandate

Insider Monkey

4 months ago

Artisan Small Cap Fund Sold argenx SE (ARGX) as it Exceeded Small-Cap Mandate

argenx Highlights FcRn Leadership with Long-term Data and Transformational Patient Outcomes at the American Academy of Neurology 2025 Annual Meeting

GlobeNewswire

4 months ago

argenx Highlights FcRn Leadership with Long-term Data and Transformational Patient Outcomes at the American Academy of Neurology 2025 Annual Meeting

Biohaven Slumps, Again, As Bipolar Setback Outweighs A $4 Billion Opportunity

Investor's Business Daily

4 months ago

Biohaven Slumps, Again, As Bipolar Setback Outweighs A $4 Billion Opportunity

Morningstar Research

4 months ago

Analyst Report: argenx SE

MT Newswires

4 months ago

Argenx's Q4 Sales Backed by Vyvgart's Growth, Oppenheimer Says

Exploring 3 High Growth Tech Stocks in Europe

Simply Wall St.

4 months ago

Exploring 3 High Growth Tech Stocks in Europe

MT Newswires

4 months ago

Argenx Q4 Swings to Earnings, Operating Income Increases

argenx Reports Full Year 2024 Financial Results and Provides Fourth Quarter Business Update

GlobeNewswire

4 months ago

argenx Reports Full Year 2024 Financial Results and Provides Fourth Quarter Business Update

argenx to Present at TD Cowen 45th Annual Healthcare Conference

GlobeNewswire

5 months ago

argenx to Present at TD Cowen 45th Annual Healthcare Conference

These Biotech Stocks Aren't Profitable But Still Make Elite IBD 50

Investor's Business Daily

5 months ago

These Biotech Stocks Aren't Profitable But Still Make Elite IBD 50

argenx to Report Full Year 2024 Financial Results and Fourth Quarter Business Update on February 27, 2025

GlobeNewswire

5 months ago

argenx to Report Full Year 2024 Financial Results and Fourth Quarter Business Update on February 27, 2025

Here’s Why argenx SE (ARGX) Rose in Q4

Insider Monkey

5 months ago

Here’s Why argenx SE (ARGX) Rose in Q4

Thomson Reuters StreetEvents

5 months ago

Q4 2024 Halozyme Therapeutics Inc Earnings Call

Is Argenx (ARGX) Outperforming Other Medical Stocks This Year?

Zacks

5 months ago

Is Argenx (ARGX) Outperforming Other Medical Stocks This Year?

Exploring High Growth Tech Stocks With Promising Potential

Simply Wall St.

5 months ago

Exploring High Growth Tech Stocks With Promising Potential

Is argenx SE (ARGX) the High Growth International Stock to Invest in Now?

Insider Monkey

6 months ago

Is argenx SE (ARGX) the High Growth International Stock to Invest in Now?

Is Ascendis Pharma (ASND) the High Growth International Stock to Invest in Now?

Insider Monkey

6 months ago

Is Ascendis Pharma (ASND) the High Growth International Stock to Invest in Now?

Earnings Estimates Rising for Argenx (ARGX): Will It Gain?

Zacks

6 months ago

Earnings Estimates Rising for Argenx (ARGX): Will It Gain?

argenx Highlights 2025 Strategic Priorities

GlobeNewswire

6 months ago

argenx Highlights 2025 Strategic Priorities

argenx to Present at 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

6 months ago

argenx to Present at 43rd Annual J.P. Morgan Healthcare Conference

Exploring High Growth Tech Stocks for January 2025

Simply Wall St.

6 months ago

Exploring High Growth Tech Stocks for January 2025

Argenx Secures Japanese Approval for VYVDURA in CIDP Treatment

TipRanks

6 months ago

Argenx Secures Japanese Approval for VYVDURA in CIDP Treatment

MT Newswires

6 months ago

Wedbush Raises Argenx's Price Target to $665 From $655, Maintains Outperform Rating

MT Newswires

6 months ago

Argenx Says Japan Approves Vyvdura Injection for Chronic Inflammatory Demyelinating Polyneuropathy

argenx Announces Approval of VYVDURA (efgartigimod alfa and hyaluronidase-qvfc) in Japan for Adults with Chronic Inflammatory Demyelinating Polyneuropathy

GlobeNewswire

6 months ago

argenx Announces Approval of VYVDURA (efgartigimod alfa and hyaluronidase-qvfc) in Japan for Adults with Chronic Inflammatory Demyelinating Polyneuropathy

Is Argenx SE (ARGX) the Best Performing Biotech Stock in 2024?

Insider Monkey

7 months ago

Is Argenx SE (ARGX) the Best Performing Biotech Stock in 2024?

Here’s Why argenx SE (ARGX) Surged in Q3

Insider Monkey

7 months ago

Here’s Why argenx SE (ARGX) Surged in Q3

Should You Increase Your Holdings in argenx SE (ARGX)?

Insider Monkey

7 months ago

Should You Increase Your Holdings in argenx SE (ARGX)?

Three Stocks Estimated To Be Undervalued In December 2024

Simply Wall St.

7 months ago

Three Stocks Estimated To Be Undervalued In December 2024

Spotlight On High Growth Tech Stocks This December 2024

Simply Wall St.

7 months ago

Spotlight On High Growth Tech Stocks This December 2024

Why Is Argenx SE (ARGX) Among the Best High Growth Healthcare Stocks to Invest In Now?

Insider Monkey

7 months ago

Why Is Argenx SE (ARGX) Among the Best High Growth Healthcare Stocks to Invest In Now?

argenx to Present at Upcoming Investor Conferences

GlobeNewswire

7 months ago

argenx to Present at Upcoming Investor Conferences

Halozyme drops Evotec buyout bid; Patient dies in Neurogene trial

BioPharma Dive

8 months ago

Halozyme drops Evotec buyout bid; Patient dies in Neurogene trial

MT Newswires

8 months ago

Sector Update: Health Care Stocks Edge Higher Premarket Wednesday

MT Newswires

8 months ago

Sector Update: Health Care

MT Newswires

8 months ago

Argenx to Continue Development of Autoimmune Disease Drug After Phase 2/3 Data

argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies

GlobeNewswire

8 months ago

argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies

Is argenx SE (ARGX) the Best Immunotherapy Stock to Buy Now?

Insider Monkey

8 months ago

Is argenx SE (ARGX) the Best Immunotherapy Stock to Buy Now?

Zai Lab and argenx Announce Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in China

Business Wire

8 months ago

Zai Lab and argenx Announce Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in China

argenx and Zai Lab Announce Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy in China

GlobeNewswire

8 months ago

argenx and Zai Lab Announce Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy in China

Why Argenx (ARGX) Might be Well Poised for a Surge

Zacks

8 months ago

Why Argenx (ARGX) Might be Well Poised for a Surge

argenx to Participate at Upcoming Investor Conferences

GlobeNewswire

8 months ago

argenx to Participate at Upcoming Investor Conferences

Three Value Stocks Priced Below Estimated Worth In November 2024

Simply Wall St.

8 months ago

Three Value Stocks Priced Below Estimated Worth In November 2024

High Growth Tech Stocks To Watch In November 2024

Simply Wall St.

8 months ago

High Growth Tech Stocks To Watch In November 2024

Argenx price target raised to $660 from $540 at Truist

TipRanks

8 months ago

Argenx price target raised to $660 from $540 at Truist

argenx SE (ARGNF) Q3 2024 Earnings Call Highlights: Strong Sales Growth and Strategic Challenges

GuruFocus.com

8 months ago

argenx SE (ARGNF) Q3 2024 Earnings Call Highlights: Strong Sales Growth and Strategic Challenges

Morningstar Research

8 months ago

Analyst Report: argenx SE

Here’s Why You Should Hold Argenx SE (ARGX)

Insider Monkey

8 months ago

Here’s Why You Should Hold Argenx SE (ARGX)

MT Newswires

8 months ago

Argenx Swings to Q3 Profit, Total Operating Income Increases

argenx Reports Third Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire

8 months ago

argenx Reports Third Quarter 2024 Financial Results and Provides Business Update

argenx to Report Third Quarter 2024 Financial Results and Business Update on October 31, 2024

GlobeNewswire

9 months ago

argenx to Report Third Quarter 2024 Financial Results and Business Update on October 31, 2024

Discover October 2024's Stocks Estimated To Be Trading Below Fair Value

Simply Wall St.

9 months ago

Discover October 2024's Stocks Estimated To Be Trading Below Fair Value

Multiple Tailwinds Lifted argenx SE (ARGX) in Q3

Insider Monkey

9 months ago

Multiple Tailwinds Lifted argenx SE (ARGX) in Q3

Share on Social Networks: